Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-R. - Université de Bretagne Occidentale Accéder directement au contenu
Article Dans Une Revue Blood Coagulation & Fibrinolysis Année : 1998

Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-R.

Résumé

Activated protein C (APC) resistance is related to a single point mutation in the factor V gene (FV:Q506) and appears to be the most common inherited risk factor for venous thromboembolism. A reliable screening test is therefore useful. We aimed to evaluate a new APC resistance test, on the basis of the procoagulant activity present in one snake venom of a crotalidae family: STA Staclot APC-R. We studied 36 consecutive patients with an acute deep venous thrombosis (DVT) confirmed by compression ultrasonography and carrying the FV:Q506 allele, assessed by DNA analysis, 103 of their family members and 35 consecutive patients with a proven DVT but who did not carry the FV:Q506 allele. Blood samples were collected within 24 h of admission for the DVT cases and on the day of medical registration for the family members. Tests were performed blind. The STA Staclot APC-R test, using a cut-off value of 0.80, had an overall sensitivity of 100% (95% CI, 95-100) and a specificity of 98.8% (95% CI, 92.0-99.6). An acute thrombosis process did not influence the performance of the test. We conclude that this test is easy and rapid to perform in every day practice and fulfills the criteria for a screening test.
Fichier non déposé

Dates et versions

hal-00722368 , version 1 (01-08-2012)

Identifiants

  • HAL Id : hal-00722368 , version 1
  • PUBMED : 9690807

Citer

Emmanuel Oger, Christophe Leroyer, Bernard Mercier, Patrick van Dreden, Luc Bressollette, et al.. Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-R.. Blood Coagulation & Fibrinolysis, 1998, 9 (4), pp.355-9. ⟨hal-00722368⟩
35 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More